Skip to main content

Table 3 Comparison of within and between group SF36 scores

From: Efficacy of ultrasound versus short wave diathermy in the treatment of chronic low back pain in patients with lumbar disk herniation: a prospective randomized control study

 

US

n = 31

KDD

n = 31

Control

n = 20

Between group

p values

Physical functioning

Before treatment

45.74 ± 21.26b

47.09 ± 20.72b

59.00 ± 27.65b

0.104*

1st month after treatment

61.51 ± 24.06b

66.77 ± 20.02b

73.00 ± 17.72b

0.172*

3rd month after treatment

61.61 ± 26.43b

70.48 ± 19.20b

75.00 ± 17.91b

0.087*

Within group p

0.003**

< 0.001**

0.036**

 

Role -physical

Before treatment

0 (0–100)c,d

0 (0–100)c,d

87.5 (0–100)c

0.002***

1st month after treatment

75 (0–100)d

100 (0–100)d

100 (0–100)

0.114***

3rd month after treatment

75 (0–100)d

100 (0–100)d

100 (0–100)

0.063***

Within group p

< 0.001****

< 0.001****

0.063****

 

Role -emotional

Before treatment

34.38 ± 39.93a,b

47.29 ± 47.75b

68.30 ± 39.75a

0.027*

1st month after treatment

64.54 ± 41.24b

76.32 ± 39.65b

80.00 ± 41.03

0.347*

3rd month after treatment

63.35 ± 41.70b

81.67 ± 35.37b

85.00 ± 36.63

0.081*

Within group p

0.001**

0.006**

0.110**

 

Vitality

Before treatment

45.48 ± 14.16b

48.38 ± 18.63b

49.50 ± 17.31

0.576*

1st month after treatment

54.83 ± 15.62b

56.45 ± 21.45b

49.75 ± 16.50

0.234*

3rd month after treatment

55.80 ± 19.58b

56.29 ± 23.55b

49.00 ± 18.32

0.075*

Within group p

0.005*

0.019*

0.957*

 

Emotional well-being

Before treatment

56.25 ± 15.69b

58.70 ± 16.21b

61.10 ± 12.40

0.382*

1st month after treatment

63.48 ± 13.13b

65.03 ± 16.68

61.30 ± 15.30

0.367*

3rd month after treatment

62.00 ± 19.34

67.61 ± 17.83b

61.15 ± 15.13

0.671*

Within group p

0.029*

0.021*

0.996*

 

Social functioning

Before treatment

50 (25–88)d

50 (25–100)d

63 (10–100)d

0.272***

1st month after treatment

63 (37.5–100)d

87.5 (0–100)d

87.5 (13–100)d

0.221***

3rd month after treatment

63 (13–100)c,d

100 (37.5–100)c,d

88 (50–100)d

0.012***

Within group p

0.001****

< 0.001****

< 0.001****

 

Pain

Before treatment

38 (0–68)c,d

45 (0–80)d

45 (23–70)c,d

0.007***

1st month after treatment

48 (10–100)d

67.5 (35–100)d

67.5 (20–90)d

0.233***

3rd month after treatment

58 (10–100)d

70 (22.5–100)d

63.7 (22.5–90)d

0.753***

Within group p

< 0.001****

< 0.001****

0.021****

 

General health

Before treatment

50 (25–80)

60 (20–85)d

57.5 (25–100)

0.132***

1st month after treatment

55 (30–80)

65 (15–95)

57.5 (30–100)

0.330***

3rd month after treatment

55 (25–95)

65 (30–95)d

62.5 (30–100)

0.215***

Within group p

0.248****

0.030****

0.590****

 

Mental Health

Before treatment

38.70 ± 18.07b

34.51 ± 15.24b

42.25 ± 18.60

0.285*

1st month after treatment

60.48 ± 26.43b

59.67 ± 23.87b

52.50 ± 26.77

0.514*

3rd month after treatment

56.61 ± 30.77b

56.41 ± 25.77b

57.50 ± 27.02

0.990*

Within group p

< 0.001**

< 0.001**

0.099**

 
  1. *One way ANOVA Test (aPosthoc: Bonferroni)
  2. **Repeated Measures ANOVA Test (bPost hoc: Paired samples T test)
  3. ***Kruskal Wallis Test (cBonferroni corrected Mann Whitney U Test, p < 0.016)
  4. ****Friedman Test (dPosthoc: Wilcoxon Signed Ranks Test)